108 related articles for article (PubMed ID: 1980342)
1. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers.
Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF
Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342
[TBL] [Abstract][Full Text] [Related]
2. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
[TBL] [Abstract][Full Text] [Related]
3. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
[TBL] [Abstract][Full Text] [Related]
4. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer].
Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG
Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692
[TBL] [Abstract][Full Text] [Related]
5. c-Ha-ras polymorphism in patients with hepatocellular carcinoma. Comparison of healthy subjects and alcoholic patients with cirrhosis.
Thelu MA; Zarski JP; Froissart B; Rachail M; Seigneurin JM
Gastroenterol Clin Biol; 1993; 17(12):903-7. PubMed ID: 7907302
[TBL] [Abstract][Full Text] [Related]
6. Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer.
Vachtenheim J; Horáková I; Novotná H
Cancer Res; 1994 Mar; 54(5):1145-8. PubMed ID: 8118795
[TBL] [Abstract][Full Text] [Related]
7. [The role of the constitutional features and rearrangement of the H-ras 1 oncogene in the development of human lung cancer].
Nikiforova IF; Maksimishina MG; Lemekhov VG; Kniazev PG
Vopr Med Khim; 1991; 37(6):64-8. PubMed ID: 1687495
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
9. Allele loss from chromosome 17 in ovarian cancer.
Russell SE; Hickey GI; Lowry WS; White P; Atkinson RJ
Oncogene; 1990 Oct; 5(10):1581-3. PubMed ID: 2250914
[TBL] [Abstract][Full Text] [Related]
10. [Loss of Ha-ras alleles in DNA from gastric carcinoma tissue of Chinese individuals].
Shan X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):171-5. PubMed ID: 1678994
[TBL] [Abstract][Full Text] [Related]
11. Association of rare alleles of the Harvey ras protooncogene locus with lung cancer.
Sugimura H; Caporaso NE; Modali RV; Hoover RN; Resau JH; Trump BF; Longergan JA; Krontiris TG; Mann DL; Weston A
Cancer Res; 1990 Mar; 50(6):1857-62. PubMed ID: 2407346
[TBL] [Abstract][Full Text] [Related]
12. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
Bouras M; Parvaz P; Berger N; Paulin C; Revol A
Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
[TBL] [Abstract][Full Text] [Related]
13. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
[TBL] [Abstract][Full Text] [Related]
14. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
Weismanová E; Kalúz S; Skorvaga M
Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer.
Türkmen B; Schmitt M; Schmalfeldt B; Trommler P; Hell W; Creutzburg S; Graeff H; Magdolen V
Electrophoresis; 1997 May; 18(5):686-9. PubMed ID: 9194591
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.
Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A
Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091
[TBL] [Abstract][Full Text] [Related]
17. Allele loss at the c-Ha-ras1 locus in human ovarian cancer.
Lee JH; Kavanagh JJ; Wharton JT; Wildrick DM; Blick M
Cancer Res; 1989 Mar; 49(5):1220-2. PubMed ID: 2917352
[TBL] [Abstract][Full Text] [Related]
18. Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer.
Ishikawa J; Maeda S; Kamidono S; Sugiyama T
Anticancer Res; 1988; 8(5A):915-24. PubMed ID: 2902823
[TBL] [Abstract][Full Text] [Related]
19. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA
Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178
[TBL] [Abstract][Full Text] [Related]
20. Ha-ras polymorphisms in epithelial ovarian cancer.
O'Briant K; Chrysson N; Hunter V; Tyson F; Tanner M; Daly L; George SL; Berchuck A; Soper J; Fowler W
Gynecol Oncol; 1992 Jun; 45(3):299-302. PubMed ID: 1351862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]